1. Product of Interest:
Coronavirus Vaccine Market
2. Research Methodology
3. Impact of COVID-19
on India Coronavirus Vaccine Market
4. Executive Summary
5. Voice of Customers/Customer Insights
6. India Coronavirus
Vaccine Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Infection Type
(SARS-CoV, MERS-CoV, SARS-CoV-2)
6.2.2. By Vaccine Type
(Virus vaccine, Viral vector vaccine, Nucleic acid vaccines, Protein based
vaccine, Others)
6.2.3. By Product Type
(Monovalent Vaccine v/s Multivariant Vaccine)
6.2.4. By Route of
Administration (Oral, Intramuscular, Intranasal)
6.2.5. By Patient Type
(Pediatric v/s Adult)
6.2.6. By End User
(Hospitals, Clinics, Research Institutes, Others)
6.2.7. By Region (North,
South, East, West)
6.2.8. By Company
6.3.
Product Market Map
7. North India
Coronavirus Vaccine Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Vaccine Type
7.2.3. By Product Type
7.2.4. By Route of
Administration
7.2.5. By Patient Type
7.2.6. By End User
8. South India
Coronavirus Vaccine Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Vaccine Type
8.2.3. By Product Type
8.2.4. By Route of
Administration
8.2.5. By Patient Type
8.2.6. By End User
9. East India
Coronavirus Vaccine Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Vaccine Type
9.2.3. By Product Type
9.2.4. By Route of
Administration
9.2.5. By Patient Type
9.2.6. By End User
10. West India
Coronavirus Vaccine Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Vaccine Type
10.2.3. By Product Type
10.2.4. By Route of
Administration
10.2.5. By Patient Type
10.2.6. By End User
11. Market Dynamics
11.1.
Drivers/Opportunities
11.2.
Challenges/Restraints
12. Market Trends &
Developments
13. Import & Export
Analysis
14. Pricing Analysis
15. Policy &
Regulatory Landscape
16. India Economic
Profile
17. Competitive
Landscape
17.1.
Company Profiles
17.1.1. Serum Institute of India Pvt. Ltd.
17.1.2. Bharat Biotech International Ltd.
17.1.3. Zydus Cadila Ltd.
17.1.4. Pfizer India Ltd.
17.1.5. Panacea Biotec Ltd.
17.1.6. Indian Immunologicals Ltd.
17.1.7. Mynvax Pvt. Ltd.
17.1.8. Biological E Ltd.
17.1.9. Hetero Biopharma Ltd.
17.1.10.
Dr
Reddy’s Laboratories Ltd.
18. Strategic
Recommendations
19. About Us &
Disclaimer
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com